Old Republic International (ORI)
(Delayed Data from NYSE)
$31.06 USD
-0.28 (-0.89%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $31.06 0.00 (0.00%) 6:22 PM ET
2-Buy of 5 2
B Value C Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$31.06 USD
-0.28 (-0.89%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $31.06 0.00 (0.00%) 6:22 PM ET
2-Buy of 5 2
B Value C Growth F Momentum C VGM
Zacks News
Marsh & McLennan (MMC) Unit's Buyout Boosts Southeast Presence
by Zacks Equity Research
Marsh & McLennan (MMC) unit Marsh acquires FBBINSURANCE of Mississippi to further strengthen its risk management services suite and Southeast presence.
Why Old Republic International (ORI) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Old Republic International (ORI) have what it takes? Let's find out.
Euronet (EEFT) Expands ATM Network in Malaysia With Buyout
by Zacks Equity Research
Euronet (EEFT) buys MEPS ATM network from Paynet in a bid to expand its reach in Southeast Asia.
Hartford Financial (HIG), Marvin Partner to Boost Mental Health
by Zacks Equity Research
Hartford Financial (HIG) collaborates with Marvin to offer specialized mental health resources to the insurer's healthcare clients, enhancing employees' well-being and productivity levels.
Manulife (MFC) Shares Rally 19% YTD: More Room for Growth?
by Zacks Equity Research
Manulife (MFC) appears well-poised for growth on its strengthening Asia business, expanding Wealth and Asset Management business, cost savings to improve profitability and solid capital position.
Here's Why You Should Stay Invested in Primerica (PRI) Stock
by Zacks Equity Research
A compelling portfolio, strong market presence and a solid capital position poise Primerica (PRI) for growth.
Here's Why You Should Add Radian Group (RDN) in Your Portfolio
by Zacks Equity Research
Radian Group (RDN) stands to gain from strong persistency rates, improved new insurance written, a strong capital position, favorable growth estimates and effective capital deployment.
Aflac (AFL), Nayya Team Up to Ease Clients' Claim Experience
by Zacks Equity Research
Aflac (AFL) joins forces with Nayya, whose medical claims integration solution will be put to use to ease claims experience and result in the higher utilization of the insurer's supplemental health benefits.
Radian (RDN) Okays Buyback to Boost Shareholder Returns
by Zacks Equity Research
Radian (RDN) board approves an increase of $600 million to its existing $300 million share buyback program to distribute wealth to shareholders.
Should You Retain Assurant (AIZ) Stock in Your Portfolio?
by Zacks Equity Research
Assurant (AIZ) stands to gain from a well-performing Global Lifestyle business, growth of fee-based capital-light businesses, solid capital management and effective capital deployment.
MGIC Investment (MTG) Up 38.8% in a Year: Will the Rally Last?
by Zacks Equity Research
MGIC Investment (MTG) stock rallies on the back of solid insurance in force, a decline in loss and claims payment, better housing market fundamentals and prudent capital deployment.
New Analysts Initiate Coverage: 3 Stocks to Add to Your Portfolio
by Shrabana Mukherjee
The recent surge in analyst coverage for stocks such as Mission Produce (AVO), iRobot (IRBT) and Old Republic (ORI) indicates the potential for significant price appreciation in the near term.
Reasons Why Investors Should Retain Everest Group (EG) Stock
by Zacks Equity Research
Everest Group (EG) is well-poised for growth on the back of an improved interest rate environment, strong renewal retention, continued favorable rate increases and a solid capital position.
Why Old Republic International (ORI) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Old Republic International (ORI) have what it takes? Let's find out.
Prudential (PRU) Rises 52.3% in a Year: Will the Rally Last?
by Zacks Equity Research
Prudential (PRU) stock rallies on the back of improved spread income, strategic acquisitions, favorable variable investment income, strong underwriting results and a solid financial position.
Aflac (AFL) Q1 Earnings Beat on Lower Benefits & Expenses
by Zacks Equity Research
Aflac (AFL) estimates improved sales in its Japan business for 2024, buoyed by sales campaigns commencing in the second quarter.
All You Need to Know About Old Republic (ORI) Rating Upgrade to Buy
by Zacks Equity Research
Old Republic (ORI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Old Republic International (ORI) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Old Republic International (ORI) have what it takes? Let's find out.
Finding Great Under-the-Radar Stocks to Buy in May
by Benjamin Rains
Investors who want to buy stocks in May and beyond might consider searching for stocks gaining more attention from Wall Street.
Compared to Estimates, Old Republic (ORI) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Old Republic (ORI) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Old Republic International (ORI) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Old Republic (ORI) delivered earnings and revenue surprises of 1.52% and 0.26%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Unveiling Old Republic (ORI) Q1 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Old Republic (ORI), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
5 Dividend-Paying Multiline Insurers Worth Watching
by Tanuka De
Multiline insurers like MetLife (MET), Prudential Financial (PRU), MGIC Investment (MTG), CNO Financial (CNO) and Old Republic (ORI), which have a solid dividend history, offer a breather amid volatility.
Old Republic's (ORI) Solid Segmental Results Aid Amid Cost Woes
by Zacks Equity Research
Old Republic (ORI) is poised to grow on solid market presence, niche focus, low property catastrophe exposure in its General Insurance segment and a strong capital position.
Compared to Estimates, Old Republic (ORI) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Old Republic (ORI) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.